Acceptance criteria and results from quality control testing of OMVs and final vaccine product MenPF-1.

*For comparison the pH of MenBvac has been in the range 5.5–7.0 (unpublished observations, NIPH).** Data presented in Fig 6. The relative IgG antibody response against OMVs is here reported as Geometric mean titre (GMT) and 95% confidence intervals (Arbitrary Units of anti-OMV IgG/mL) in serum after 2 doses of 2.5 μg OMV protein 3 weeks apart, 2 weeks after last dose.Acceptance criteria and results from quality control testing of OMVs and final vaccine product MenPF-1.